Pharmaceutical Industry is one of the most critical industries
with its production volume and trade capacity.
The point that differs pharmaceutical sector from other sectors
is the nature of pharmaceutical products that are not suitable for
replacement for many reasons. Due to the dynamics of the
pharmaceutical industry, it is one of the most significant and
crucial sectors in the world considering the cyclical trends will
be in the future.
In last five-years period pharmaceutical industry growth has
approached almost 4,3 %, and in the last three years the size of
the market has reached to more than 700 USD million USD
In accordance with the technological developments and new
legislations regarding patent protections it seems that
pharmaceutical industry will be also on the rise in the forthcoming
years in business perspective.
In 2006, 16 % of total growth in pharmaceutical industry belongs
to emerging countries. In 2009 it was 51 % and now it is expected
to raise more than 75 %. Therefore, multinationals in this industry
mostly focus on the pharmaceutical companies in developing
countries. Increase in research & development numbers in
developing countries, makes them attractive more than ever.
Health Sector and Pharmaceutical Industry in Turkey
Health sector in Turkey has been on the rise for the last five
years. It seems that due to developments in pharmaceutical
industry, healthcare service, insurance and medical devices, Turkey
has now become one of the important developing countries for the
healthcare sector and pharmaceutical industry.
Turkey has developed its healthcare sector as the result of
government policies in this area together with FDI regime and
appeared in one of the thriving economies. Since thriving economy
reflects on the healthcare service access, health expenses have
been increasing and Turkey's place among the other countries
has been becoming stronger.
Healthcare sector has been on the rise for the last ten years.
Turkey's health expenses have approached approximately 7 %
which is the same among other developing countries. Besides,
hospitals have been increasing in number in Turkey. In 2002, for
instance, total hospitals in Turkey were almost 267; however, in
2010 the numbers rose to 489.
For the pharmaceutical industry, Turkey has become 13th biggest
in the world pharmaceutical industry. In 2012, Turkey
pharmaceutical market volume was totally USD 8 billions on the
basis of producer price index and Turkey pharmaceutical market is
the sixth biggest market among European Union Countries. Besides,
Turkey's pharmaceutical importation has reached USD 5 billion
in recent years.
In 2013 over 1.75 billion boxes were sold and the volume reached
over TL 15 billion which correspondence 7 % growth when compared to
year of 2012.
Mergers and Acquisitions Continue in the Market
In determination of the pharmaceutical market in Turkey, it is
obviously observed that investors prefer to acquire existing
pharmaceutical companies in Turkey rather than establishing a new
one since existing pharmaceutical companies are generally
well-established and capable of realizing know-how in the market.
In 2013, there were several mergers and acquisitions both in
pharmaceutical companies and pharmaceutical warehouses.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Inquests are something which affect a vast range of NHS and private organisations, as well as individual clinicians, and so we provide a brief overview of recent developments as well as a couple of key potential changes to come.
Le 28 janvier dernier, le Président du Tribunal de grande instance de Nanterre, statuant en référé, a accordé des dommages et intérêts au titre du préjudice d'anxiété à certaines victimes du Mediator dans trois jugements.
The Turkish Competition Board has launched an investigation into the alleged blocking by the Turkish Pharmacists Union of "named patient sales" by pharmaceutical warehouses.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).